Taken together, above results indicated that combined administration of MWCNTs and PbAc may exert its hepatotoxicity to NAFLD mice via inhibiting AMPK/PPARγ pathway. Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.